Cite
Carpéné C, Boulet N, Chaplin A, et al. Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors. Medicines (Basel). 2019;6(1)doi: 10.3390/medicines6010009.
Carpéné, C., Boulet, N., Chaplin, A., & Mercader, J. (2019). Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors. Medicines (Basel, Switzerland), 6(1), . https://doi.org/10.3390/medicines6010009
Carpéné, Christian, et al. "Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors." Medicines (Basel, Switzerland) vol. 6,1 (2019). doi: https://doi.org/10.3390/medicines6010009
Carpéné C, Boulet N, Chaplin A, Mercader J. Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors. Medicines (Basel). 2019 Jan 15;6(1). doi: 10.3390/medicines6010009. PMID: 30650583; PMCID: PMC6473341.
Copy
Download .nbib